Results 81 to 90 of about 23,012 (218)
Measles-Mumps-Rubella and Other Measles-Containing Vaccines Do Not Increase the Risk for Inflammatory Bowel Disease<subtitle>A Case-Control Study From the Vaccine Safety Datalink Project</subtitle> [PDF]
, 2001 Robert L. Davis
openalex +1 more source
Impact of local vaccine subsidization programs on the prevention of mumps in Japan [PDF]
, 2021 Makoto Miyazaki +2 more
openalex +1 more source
The Turkish Journal of Pediatrics, 2000 A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj
Genetics and measles, mumps and rubella vaccine response in childhood and adolescence—A systematic review [PDF]
, 2023 Marie Mykløy Haslund +2 more
openalex +1 more source
Economic Benefits of a Routine Second Dose of Combined Measles, Mumps and Rubella Vaccine in Canada [PDF]
, 1997 Marc Rivière +4 more
openalex +1 more source
Measles, mumps, and rubella vaccine: time for a two stage policy. [PDF]
, 1992 D. S. Sloan
openalex +1 more source
Clinical and laboratorial aspects of aseptic meningitis associated with MMR (measles-mumps-rubella) vaccine at a referral hospital in the State of Bahia [PDF]
, 2002 Rita Lucena
openalex +1 more source